- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: May 2, 2015
A one-minute look at managed care news during the week of April 27, 2015, including more good news for the much-anticipated PCSK9 inhibitors and growth in the individual insurance market enrollment.
This week, a meta-analysis in JAMA confirmed that the PCSK9 inhibitors dramatically reduce low-density lipoprotein as well as all-cause mortality and cardiovascular mortality. However, an accompanying editorial cautioned against too much enthusiasm.
A new report from the Kaiser Family Foundation found that enrollment in the individual insurance market grew in 2014 after the first open enrollment period of the Affordable Care Act. Enrollment is expected to continue to grow in 2015, but at a slower pace.
The first videos from the Spring 2015 Oncology Stakeholders Summit is now available online here.
Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis
February 6th 2026Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL measures into trials is urgently needed.
Read More
